Due to be held from September 29 to October 2, 2010, the events will examine the future of research in the field and the latest business and regulatory issues.
CRN’s one-day scientific symposium will take place on September 29 in Austin, Texas. The day will be divided into four scientific sessions, which will each focus on a different aspect of dietary supplement research.
The first session is on biomarkers and will include presentations from: John Milner, of the National Institutes of Health, National Cancer Institute; Renger Witkamp of Wageningen University, The Netherlands; and Ronald Krauss, Children’s Hospital Oakland Research Institute, and member of the Institute Of Medicine (IOM) expert committee on the topic of biomarkers.
The second session will address science informing policy decisions. This will be given by Robin Marles of Health Canada, who will examine how science drives policy, based on case histories.
The third session will examine recent advances in nutrigenomics and nutrigenetics, with speakers including Robert Superko, Celera; Steven Zeisel, University of North Carolina; and Ray Rodriguez, University of California, Davis.
The final session will take a look to the future, with a presentation by George Burdock, of the Burdock Group on the application of nanotechnology research to dietary supplements.
Keynote speaker at the event is Eileen Kennedy, dean, Tufts Friedman School of Nutrition, Science and Policy, with an address entitled Overfed and undernutrified: A global perspective on the role of dietary supplements in dietary guidance.
For more information and to register, click here.
CRN’s scientific workshop will be followed by its annual conference, due to be held from the evening of September 29 to October 2.
Topics on the agenda include a presentation on dietary supplement regulation, as well as a discussion on healthcare reform. Other sessions include advertising supplements and communicating to young consumers; how supplements fit into wellness and prevention; and “what our consumers want”.
For more information, click here.